CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-20 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise · Restricted Stock Unit | +4,625 | 13,875 | ||
| 2024-02-20 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise · Restricted Stock Unit | +2,755 | 5,509 | ||
| 2024-02-20 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +3,000 | 56,984 | ||
| 2024-02-20 | Hopper Jonathan Mark Chief Medical Officer | Shares withheld for taxes | −1,379 | $49.50 | $68K | 55,605 |
| 2024-02-20 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +2,325 | 57,930 | ||
| 2024-02-20 | Hopper Jonathan Mark Chief Medical Officer | Shares withheld for taxes | −985 | $49.50 | $49K | 56,945 |
| 2024-02-20 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +1,750 | 58,695 | ||
| 2024-02-20 | Hopper Jonathan Mark Chief Medical Officer | Shares withheld for taxes | −742 | $49.50 | $37K | 57,953 |
| 2024-02-20 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Restricted Stock Unit | +3,000 | 9,000 | ||
| 2024-02-20 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Restricted Stock Unit | +2,325 | 4,650 | ||
| 2024-02-20 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Restricted Stock Unit | +1,750 | 1,750 | ||
| 2024-02-15 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +17,500 | $3.02 | $53K | 191,508 |
| 2024-02-15 | Colangelo Dominick President and CEO | Sale 10b5-1 | −17,500 | $48.85 | $855K | 174,008 |
| 2024-02-15 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +17,500 | 315,000 | ||
| 2024-02-14 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +17,500 | $3.02 | $53K | 191,508 |
| 2024-02-14 | Colangelo Dominick President and CEO | Sale 10b5-1 | −17,500 | $46.99 | $822K | 174,008 |
| 2024-02-14 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +17,500 | 332,500 | ||
| 2024-02-12 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +1,625 | 54,759 | ||
| 2024-02-12 | Hopper Jonathan Mark Chief Medical Officer | Shares withheld for taxes | −775 | $47.42 | $37K | 53,984 |
| 2024-02-12 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Restricted Stock Unit | +1,625 | 0 |
Page 32 of 75 · 1,497 trades